Multiple Myeloma Dispensing Models Webinar SeriesContains 11 Component(s) Includes a Live Web Event on 11/04/2020 at 3:00 PM (EST)
The ACCC Multiple Myeloma Dispensing Models Webinar Series features one live webinar and five on-demand recordings that explore various dispensing models and effective practices in the care of patients with multiple myeloma.
Characterizing and Targeting Tumor Immune Microenvironment in FGFR-Mutated Bladder CancerContains 2 Component(s)
Webinar for TxSCO
Optimizing Outcomes for Patients with Urothelial Carcinoma: Recent Clinical UpdatesContains 5 Component(s), Includes Credits
Component Credit Type State/Medical Type Available Credits Earned Credits CME/CNE/Certificate of Participation Medical CME 0.75 0.00 CME/CNE/Certificate of Participation Medical CNE 0.75 0.00 CME/CNE/Certificate of Participation Medical Certificate of Participation 0.75 0.00
In a recent survey of community cancer care professionals conducted by the Association of Community Cancer Centers, bladder was reported to be one of the most commonly diagnosed cancers after breast, lung, prostate, and colorectal. For many community oncologists, it is hard to stay abreast of clinical updates and changing treatment recommendations across all tumor types. This initiative will summarize recent clinical data for immunotherapies and emerging targeted therapies used to treat advanced and metastatic urothelial carcinoma. Strategies for identification and management of treatment-related adverse events, as well as effective solutions for improving multidisciplinary care coordination, will also be covered.
Chronic Lymphocytic Leukemia: Up-to-Date Approaches to CareContains 4 Component(s)
Listen to current treatment approaches for patients with newly diagnosed through relapsed chronic lymphocytic leukemia (CLL) with an emphasis on the latest data from the 2018 ASH Annual Meeting.
Acute Lymphocytic Leukemia: Supporting the Patient JourneyContains 4 Component(s)
Listen to perspectives on how to effectively support patients diagnosed with acute lymphocytic leukemia (ALL) throughout the care journey from multidisciplinary cancer team members and a patient representative.
Acute Lymphocytic Leukemia: Critical InsightsContains 4 Component(s)
Using a case-based approach, experts discuss current treatment strategies for Ph(+) and Ph(-) patients, and take a closer look at the role of minimal residual disease (MRD) for prognosis and treatment selection.
|Access Date||Quiz Result||Score||Actions|